APO RESEARCH · REPORT
Urokinase
Urokinase, also known as urokinase-type plasminogen activator (uPA), is a serine protease present in humans and other animals. The human urokinase protein was discovered, but not named, by McFarlane and Pilling in 1947. Urokinase was originally isolated from human urine, and it is also present in the blood and in the extracellular matrix of many tissues. The primary physiological substrate of this enzyme is plasminogen, which is an inactive form (zymogen) of the serine protease plasmin.
Product & engineering
Understand the product.
Urokinase, also known as urokinase-type plasminogen activator (uPA), is a serine protease present in humans and other animals. The human urokinase protein was discovered, but not named, by McFarlane and Pilling in 1947. Urokinase was originally isolated from human urine, and it is also present in the blood and in the extracellular matrix of many tissues. The primary physiological substrate of this enzyme is plasminogen, which is an inactive form (zymogen) of the serine protease plasmin.
Selected research
Industry Research
Urokinase Industry Research Report 2026
Market perspective
Urokinase, also known as urokinase-type plasminogen activator (uPA), is a serine protease present in humans and other animals. The human urokinase protein was discovered, but not named, by McFarlane and Pilling in 1947. Urokinase was originally isolated from human urine, and it is also present in the blood and in the extracellular matrix of many tissues. The primary physiological substrate of this enzyme is plasminogen, which is an inactive form (zymogen) of the serine protease plasmin.
Global Urokinase (CAS 9039-53-6) main manufactuers include Syner-Med, LIVZON, Wanhua Biochem and Techpool, totally accounting for about 50% of the market. China is the largest market of Urokinase (CAS 9039-53-6), holding a share about 56%. As for the types of products, it can be divided into urokinase powder and urokinase polution. The most common type is urokinase powder, with a share about 92%. As for the applications of products, it is widely used in hospitals, clinics and others. The most common application is in hospitals, with a share about 78%.
Report Scope
Read the full market overview
This report quantifies the global Urokinase market in terms of revenue (US$ million) and, where applicable, sales volume (BIU), using 2025 as the base year and providing annual historical and forecast data for 2021–2032.
It standardizes definitions of Types and Applications, harmonizes vendor attribution, and presents comparable time series by company, Type, Application, and region/country, including indicative price bands (US$/BIU) and concentration ratios (CR5/CR10).
The outputs are intended to support strategy development, budgeting, and performance benchmarking for brand owners, manufacturers, retailers, channel partners, and investors; data are structured with consistent units and fields to facilitate integration into internal FP&A and BI systems.
Key Companies & Market Share Insights
This section profiles leading manufacturers, combining 2021–2025 results with a 2026–2032 outlook. It reports revenue, market share, price bands, product and application mix, regional and channel mix, and key developments (M&A, capacity additions, certifications). It also provides global revenue, average price, and—where applicable—sales volume by manufacturer, and calculates CR5/CR10 and rank changes to support comparative benchmarking.
Urokinase Market by Company
Syner-Med
Wanhua Biochem
Jiangxi Haoran Bio-Pharma
Jiangsu Aidea Pharmaceutical
Techpool
Microbic Biosystems
LIVZON
Urokinase Segment by Type
Urokinase Powder
Urokinase Solution
Urokinase Segment by Application
Hospital
Clinic
Others
Urokinase Segment by Region
North America
United States
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Spain
Netherlands
Switzerland
Sweden
Poland
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Southeast Asia
South America
Brazil
Argentina
Chile
Colombia
Middle East & Africa
Egypt
South Africa
Israel
Türkiye
GCC Countries
Key Drivers & Barriers
High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Urokinase market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Urokinase and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market
5. This report helps stakeholders to gain insights into which regions to target globally
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Urokinase.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Research objectives, research methods, data sources, data cross-validation;
Chapter 2: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc.), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 3: Detailed analysis of Urokinase manufacturers competitive landscape, price, production and value market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product production/output, value, price, gross margin, product introduction, recent development, etc.
Chapter 5: Production/output, value of Urokinase by region/country. It provides a quantitative analysis of the market size and development potential of each region in the next six years.
Chapter 6: Consumption of Urokinase in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and production of each country in the world.
Chapter 7: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 8: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 10: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 11: The main points and conclusions of the report.
More report detail
Tables and figures
Scope & coverage.
Types
- Urokinase Powder
- Urokinase Solution
Applications
- Hospital
- Clinic
- Others
Companies covered
- Syner-Med
- Wanhua Biochem
- Jiangxi Haoran Bio-Pharma
- Jiangsu Aidea Pharmaceutical
- Techpool
- Microbic Biosystems
- LIVZON
Inside the report.
1 Preface
- 1.1 Scope of Report
- 1.2 Reasons for Doing This Study
- 1.3 Research Methodology
- 1.4 Research Process
- 1.5 Data Source
- 1.5.1 Secondary Sources
- 1.5.2 Primary Sources
2 Market Overview
- 2.1 Product Definition
- 2.2 Global Market Growth Prospects
- 2.2.1 Global Urokinase Market Size (2021-2032)
- 2.2.2 Global Urokinase Sales (2021-2032)
- 2.2.3 Global Urokinase Market Average Price (2021-2032)
- 2.3 Urokinase by Type
- 2.3.1 Market Value Comparison by Type (2021 VS 2025 VS 2032) & (US$ Million)
- 2.3.2 Urokinase Powder
- 2.3.3 Urokinase Solution
- 2.4 Urokinase by Application
- 2.4.1 Market Value Comparison by Application (2021 VS 2025 VS 2032)
- 2.4.2 Hospital
- 2.4.3 Clinic
- 2.4.4 Others
3 Market Competitive Landscape by Manufacturers
- 3.1 Global Urokinase Market Competitive Situation by Manufacturers (2021 Versus 2025)
- 3.2 Global Urokinase Sales (BIU) of Manufacturers (2021-2026)
- 3.3 Global Urokinase Revenue of Manufacturers (2021-2026)
- 3.4 Global Urokinase Average Price by Manufacturers (2021-2026)
- 3.5 Global Urokinase Industry Ranking, 2024 VS 2025 VS 2026
- 3.6 Global Manufacturers of Urokinase, Manufacturing Sites & Headquarters
- 3.7 Global Manufacturers of Urokinase, Product Type & Application
- 3.8 Global Manufacturers of Urokinase, Established Date
- 3.9 Global Urokinase Market CR5 and HHI
- 3.10 Global Manufacturers Mergers & Acquisition
4 Manufacturers Profiled
- 4.1 Syner-Med
- 4.1.1 Syner-Med Company Information
- 4.1.2 Syner-Med Business Overview
- 4.1.3 Syner-Med Urokinase Sales, Revenue and Gross Margin (2021-2026)
- 4.1.4 Syner-Med Urokinase Product Portfolio
- 4.1.5 Syner-Med Recent Developments
- 4.2 Wanhua Biochem
- 4.2.1 Wanhua Biochem Company Information
- 4.2.2 Wanhua Biochem Business Overview
- 4.2.3 Wanhua Biochem Urokinase Sales, Revenue and Gross Margin (2021-2026)
- 4.2.4 Wanhua Biochem Urokinase Product Portfolio
- 4.2.5 Wanhua Biochem Recent Developments
- 4.3 Jiangxi Haoran Bio-Pharma
- 4.3.1 Jiangxi Haoran Bio-Pharma Company Information
- 4.3.2 Jiangxi Haoran Bio-Pharma Business Overview
- 4.3.3 Jiangxi Haoran Bio-Pharma Urokinase Sales, Revenue and Gross Margin (2021-2026)
- 4.3.4 Jiangxi Haoran Bio-Pharma Urokinase Product Portfolio
- 4.3.5 Jiangxi Haoran Bio-Pharma Recent Developments
- 4.4 Jiangsu Aidea Pharmaceutical
- 4.4.1 Jiangsu Aidea Pharmaceutical Company Information
- 4.4.2 Jiangsu Aidea Pharmaceutical Business Overview
- 4.4.3 Jiangsu Aidea Pharmaceutical Urokinase Sales, Revenue and Gross Margin (2021-2026)
- 4.4.4 Jiangsu Aidea Pharmaceutical Urokinase Product Portfolio
- 4.4.5 Jiangsu Aidea Pharmaceutical Recent Developments
- 4.5 Techpool
- 4.5.1 Techpool Company Information
- 4.5.2 Techpool Business Overview
- 4.5.3 Techpool Urokinase Sales, Revenue and Gross Margin (2021-2026)
- 4.5.4 Techpool Urokinase Product Portfolio
- 4.5.5 Techpool Recent Developments
- 4.6 Microbic Biosystems
- 4.6.1 Microbic Biosystems Company Information
- 4.6.2 Microbic Biosystems Business Overview
- 4.6.3 Microbic Biosystems Urokinase Sales, Revenue and Gross Margin (2021-2026)
- 4.6.4 Microbic Biosystems Urokinase Product Portfolio
- 4.6.5 Microbic Biosystems Recent Developments
- 4.7 LIVZON
- 4.7.1 LIVZON Company Information
- 4.7.2 LIVZON Business Overview
- 4.7.3 LIVZON Urokinase Sales, Revenue and Gross Margin (2021-2026)
- 4.7.4 LIVZON Urokinase Product Portfolio
- 4.7.5 LIVZON Recent Developments
5 Global Urokinase Market Scenario by Region
- 5.1 Global Urokinase Market Size by Region: 2021 VS 2025 VS 2032
- 5.2 Global Urokinase Sales by Region: 2021-2032
- 5.2.1 Global Urokinase Sales by Region: 2021-2026
- 5.2.2 Global Urokinase Sales by Region: 2027-2032
- 5.3 Global Urokinase Revenue by Region: 2021-2032
- 5.3.1 Global Urokinase Revenue by Region: 2021-2026
- 5.3.2 Global Urokinase Revenue by Region: 2027-2032
- 5.4 North America Urokinase Market Facts & Figures by Country
- 5.4.1 North America Urokinase Market Size by Country: 2021 VS 2025 VS 2032
- 5.4.2 North America Urokinase Sales by Country (2021-2032)
- 5.4.3 North America Urokinase Revenue by Country (2021-2032)
- 5.4.4 United States
- 5.4.5 Canada
- 5.4.6 Mexico
- 5.5 Europe Urokinase Market Facts & Figures by Country
- 5.5.1 Europe Urokinase Market Size by Country: 2021 VS 2025 VS 2032
- 5.5.2 Europe Urokinase Sales by Country (2021-2032)
- 5.5.3 Europe Urokinase Revenue by Country (2021-2032)
- 5.5.4 Germany
- 5.5.5 France
- 5.5.6 U.K.
- 5.5.7 Italy
- 5.5.8 Russia
- 5.5.9 Spain
- 5.5.10 Netherlands
- 5.5.11 Switzerland
- 5.5.12 Sweden
- 5.5.13 Poland
- 5.6 Asia Pacific Urokinase Market Facts & Figures by Country
- 5.6.1 Asia Pacific Urokinase Market Size by Country: 2021 VS 2025 VS 2032
- 5.6.2 Asia Pacific Urokinase Sales by Country (2021-2032)
- 5.6.3 Asia Pacific Urokinase Revenue by Country (2021-2032)
- 5.6.4 China
- 5.6.5 Japan
- 5.6.6 South Korea
- 5.6.7 India
- 5.6.8 Australia
- 5.6.9 Taiwan
- 5.6.10 Southeast Asia
- 5.7 South America Urokinase Market Facts & Figures by Country
- 5.7.1 South America Urokinase Market Size by Country: 2021 VS 2025 VS 2032
- 5.7.2 South America Urokinase Sales by Country (2021-2032)
- 5.7.3 South America Urokinase Revenue by Country (2021-2032)
- 5.7.4 Brazil
- 5.7.5 Argentina
- 5.7.6 Chile
- 5.7.7 Colombia
- 5.8 Middle East and Africa Urokinase Market Facts & Figures by Country
- 5.8.1 Middle East and Africa Urokinase Market Size by Country: 2021 VS 2025 VS 2032
- 5.8.2 Middle East and Africa Urokinase Sales by Country (2021-2032)
- 5.8.3 Middle East and Africa Urokinase Revenue by Country (2021-2032)
- 5.8.4 Egypt
- 5.8.5 South Africa
- 5.8.6 Israel
- 5.8.7 Türkiye
- 5.8.8 GCC Countries
6 Segment by Type
- 6.1 Global Urokinase Sales by Type (2021-2032)
- 6.1.1 Global Urokinase Sales by Type (2021-2032) & (BIU)
- 6.1.2 Global Urokinase Sales Market Share by Type (2021-2032)
- 6.2 Global Urokinase Revenue by Type (2021-2032)
- 6.2.1 Global Urokinase Sales by Type (2021-2032) & (US$ Million)
- 6.2.2 Global Urokinase Revenue Market Share by Type (2021-2032)
- 6.3 Global Urokinase Price by Type (2021-2032)
7 Segment by Application
- 7.1 Global Urokinase Sales by Application (2021-2032)
- 7.1.1 Global Urokinase Sales by Application (2021-2032) & (BIU)
- 7.1.2 Global Urokinase Sales Market Share by Application (2021-2032)
- 7.2 Global Urokinase Revenue by Application (2021-2032)
- 7.2.1 Global Urokinase Sales by Application (2021-2032) & (US$ Million)
- 7.2.2 Global Urokinase Revenue Market Share by Application (2021-2032)
- 7.3 Global Urokinase Price by Application (2021-2032)
8 Value Chain and Sales Channels Analysis of the Market
- 8.1 Urokinase Value Chain Analysis
- 8.1.1 Urokinase Key Raw Materials
- 8.1.2 Raw Materials Key Suppliers
- 8.1.3 Urokinase Production Mode & Process
- 8.2 Urokinase Sales Channels Analysis
- 8.2.1 Direct Comparison with Distribution Share
- 8.2.2 Urokinase Distributors
- 8.2.3 Urokinase Customers
9 Global Urokinase Analyzing Market Dynamics
- 9.1 Urokinase Industry Trends
- 9.2 Urokinase Industry Drivers
- 9.3 Urokinase Industry Opportunities and Challenges
- 9.4 Urokinase Industry Restraints
10 Report Conclusion
11 Disclaimer
GET THE RESEARCH
Choose your license.
Choose who needs access.
All options are for this report and research series.
PDF by email within 3–5 working days after payment confirmation.
Talk to an analyst